Helensville and Hamilton are two of the meth lab hotspots identified in the first study of clandestine meth lab distribution in New Zealand.
Strong regional trends were identified in the research from the University of Auckland.
Researchers, Drs Daniel Exeter and David Newcombe, from the University’s School of Population Health, say that by mapping the location of laboratory seizures and performing cluster analyses of the data from NZ Police between 2004 and 2009, they were able to identify five hot spots of clandestine laboratory activity.
“The majority of methamphetamine laboratories were found in the north of the North Island, within the central Auckland, west Auckland, Hamilton, and Far North Territorial Authorities,” says Dr Exeter.
The research findings were published this week in the journal Policing: A Journal of Policy and Practice, in the first New Zealand study to investigate distribution of meth labs in New Zealand and explore potential socio-economic and ecological predictors.
Dr Exeter says, “We found a strong regional variation in the presence of clandestine meth labs in New Zealand. There were few reported clandestine meth labs seized in the South Island and 69 per cent of seizures were located in the upper North Island.
“The upper half of the North Island, particularly in parts of Auckland, was consistently identified as having a high concentration of clandestine laboratories, even after adjusting for population size.”
Four socio-economic factors did have a mild influence on the distribution of clandestine laboratories. Their research using 2006 Census data found areas with a younger median age, lower median income, and rural land use type were at greater risk for harbouring clandestine laboratories.
“But none of the factors were able to explain the presence of all five of our initial clusters at the Census Area Unit level,” Dr Exeter says.
“The persistence of the Helensville and Hamilton clusters (after adjusting for these four socioeconomic factors), suggests there are other unknown factors influencing the geography of clandestine methamphetamine laboratories in the North Island,” he says.
The research looked at data from 2004 and 2009 and a recent update of that data from the New Zealand Police for the 2010-2015 period, showed there were 561 clandestine meth lab seizures reported between 2010 and 2015.
The annual count of seizures reduced from 130 in 2010 to 68 during 2015 and the majority of seizures (57 per cent) between 2010 and 2015, occurred at residential localities.
“This figure included seizures in commercial properties (such as factories) with residential facilities located within that property,” Dr Exeter says. “This was consistent with the findings from 2004-2009.”
“Areas identified as “hot spots” of clandestine meth lab activity represent an opportunity to target prevention and treatment resources, including community-level interventions and educational campaigns,” Dr Newcombe says.
“If community awareness of the harms associated with meth labs is an influential factor in clandestine meth lab presence, then educational campaigns may be effective at changing community attitudes towards methamphetamine use and manufacture,” he says.
“This research also demonstrates the utility of geographic techniques in displaying health and crime data. Future law enforcement and public health intervention efforts would benefit from incorporating GIS into their surveillance and data management infrastructure,” Dr Newcombe days.
“For instance, a national clandestine methamphetamine laboratory registry accessible to the public may be beneficial to potential home owners and renters who want to ensure their families are protected from exposure to methamphetamine contaminated properties,” he says.